Academic literature on the topic 'Prophylactic treatment of diarrhoea'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Prophylactic treatment of diarrhoea.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Prophylactic treatment of diarrhoea"

1

Bharadwaj, Shruthi Kumar, Sheila Samanta Mathai, Smriti Bhargava, and Leslie Edward S. Lewis. "Chronic diarrhoea due to trichohepatoenteric syndrome (THES) in an infant." BMJ Case Reports 17, no. 2 (2024): e257746. http://dx.doi.org/10.1136/bcr-2023-257746.

Full text
Abstract:
An infant was admitted with suspected postinfectious malabsorption with watery diarrhoea, fever and failure to thrive. She had dehydration, acute kidney injury and metabolic acidosis, which were corrected with intravenous fluids and managed with empiric antibiotics and prophylactic antifungals. She also developedEscherichia colisepsis, meningitis and Candida skin infections during hospitalisation, which were treated according to the culture reports. Intrauterine growth restriction, woolly hair and a broad nasal bridge with chronic refractory diarrhoea prompted genetic testing to rule out syndr
APA, Harvard, Vancouver, ISO, and other styles
2

Diemert, David J. "Prevention and Self-Treatment of Traveler's Diarrhea." Clinical Microbiology Reviews 19, no. 3 (2006): 583–94. http://dx.doi.org/10.1128/cmr.00052-05.

Full text
Abstract:
SUMMARYOf the millions who travel from the industrialized world to developing countries every year, between 20% and 50% will develop at least one episode of diarrhea, making it the most common medical ailment afflicting travelers. Although usually a mild illness, traveler's diarrhea can result in significant morbidity and hardship overseas. Precautions can be taken to minimize the risk of developing traveler's diarrhea, either through avoidance of potentially contaminated food or drink or through various prophylactic measures, including both nonpharmacological and antimicrobial strategies. If
APA, Harvard, Vancouver, ISO, and other styles
3

Jamil, Muhammad Omer, Maira Rizwan, and John T. Carpenter. "Prophylactic use of antidiarrheal agents to control diarrhea associated with lapatinib therapy in breast cancer patients." Journal of Clinical Oncology 33, no. 29_suppl (2015): 205. http://dx.doi.org/10.1200/jco.2015.33.29_suppl.205.

Full text
Abstract:
205 Background: Lapatinib causes diarrhea in about 40-50% of patients treated with it for HER-2 positive breast cancer. It is the major dose and treatment limiting toxicity of lapatinib. Methods: This is a retrospective review of a cohort of patients treated with lapatinib for HER2 positive breast cancer at the Kirklin clinic at the University of Alabama at Birmingham from January 1, 2009 through September 30, 2013. Loperamide 2-8mg before lapatinib dose was recommended for prophylaxis in patients who developed clinically significant diarrhea. Additional doses of loperamide were used if needed
APA, Harvard, Vancouver, ISO, and other styles
4

Harder, Helena, Valerie M. Shilling, Shirley F. May, David Cella, Peter Schmid, and Lesley J. Fallowfield. "The development and initial evaluation of the Diarrhoea Management Diary (DMD) in patients with metastatic breast cancer." Breast Cancer Research and Treatment 183, no. 3 (2020): 629–38. http://dx.doi.org/10.1007/s10549-020-05798-w.

Full text
Abstract:
Abstract Purpose Chemotherapy-induced diarrhoea (CID) is a common, but often underreported problem in patients with breast cancer that has a profound effect on quality of life. It is best measured from a patient’s perspective, but tools are limited. The aim of this study was to develop and evaluate the Diarrhoea Management Diary (DMD), a self-report measure to assess CID, use of self-management strategies and treatment adherence. Methods The DMD was constructed using an iterative process of instrument development: concept elicitation (literature review), item generation and reduction (cognitiv
APA, Harvard, Vancouver, ISO, and other styles
5

Timko, Jaroslav. "Probiotics as prevention of radiation-induced diarrhoea." Journal of Radiotherapy in Practice 9, no. 4 (2010): 201–8. http://dx.doi.org/10.1017/s1460396910000087.

Full text
Abstract:
AbstractAim: To assess the efficacy of a probiotic preparation on the prevention of radiation-induced diarrhoea in cancer patients.Methods: Group of 42 radio-oncology patients who had undergone adjuvant post-operative radiation therapy (RT) after abdominal and pelvic cancer were randomised to receive either the probiotic preparation “5” Strain Dophilus (twice per day; L-Group), or the preparation Hylak Tropfen Forte (40 drops, three times per day; H-Group). Supplementation started on the first day and lasted until the end of RT. Efficacy endpoints were the incidence and the severity of the rad
APA, Harvard, Vancouver, ISO, and other styles
6

Bonafede, Machaon, Kathleen Wilson, and Fei Xue. "Long-term treatment patterns of prophylactic and acute migraine medications and incidence of opioid-related adverse events in patients with migraine." Cephalalgia 39, no. 9 (2019): 1086–98. http://dx.doi.org/10.1177/0333102419835465.

Full text
Abstract:
Objectives To describe long-term treatment patterns in migraine patients initiating prophylactic therapy and to evaluate acute medication use and adverse events associated with opioids. Methods This study used the 2005–2014 IBM MarketScan® databases to evaluate migraine patients initiating prophylactic medication. Outcome measures included persistence with prophylactic migraine medications over 2–5 years. Acute medication use and gastrointestinal-related adverse events and opioid abuse following opioid use were evaluated. Cox proportional hazards models were used to evaluate predictors of non-
APA, Harvard, Vancouver, ISO, and other styles
7

Islam, Dilara, Nattaya Ruamsap, Rawiwan Imerbsin, et al. "Bioactivity and efficacy of a hyperimmune bovine colostrum product- Travelan, against shigellosis in a non-Human primate model (Macaca mulatta)." PLOS ONE 18, no. 12 (2023): e0294021. http://dx.doi.org/10.1371/journal.pone.0294021.

Full text
Abstract:
Infectious diarrhea is a World Health Organization public health priority area due to the lack of effective vaccines and an accelerating global antimicrobial resistance crisis. New strategies are urgently needed such as immunoprophylactic for prevention of diarrheal diseases. Hyperimmune bovine colostrum (HBC) is an established and effective prophylactic for infectious diarrhea. The commercial HBC product, Travelan® (Immuron Ltd, Australia) targets multiple strains of enterotoxigenic Escherichia coli (ETEC) is highly effective in preventing diarrhea in human clinical studies. Although Travelan
APA, Harvard, Vancouver, ISO, and other styles
8

Gorelov, A. V., Е. V. Kanner, M. L. Maximov, A. S. Ermolaeva, A. A. Voznesenskaya, and K. N. Dadasheva. "Lactobacillus rhamnosus GG: clinical aspects of the use from the perspective of evidence-based medicine." Medical Council, no. 17 (October 22, 2018): 66–73. http://dx.doi.org/10.21518/2079-701x-2018-17-66-73.

Full text
Abstract:
This review provides information on the composition and functions of the intestinal microbiota, its role in the immune development. At present, prophylactic and therapeutic uses of probiotics are widely common for a variety of pathological conditions, however they have proven efficacy only in certain diseases. This review provides information on the efficacy of the use of probiotic microorganismL. rhamnosusGG in the paediatric practice as one of the most studied and tested strains. It summarized the currently available evidence on the efficacy of its use for the treatment of acute diarrhea, th
APA, Harvard, Vancouver, ISO, and other styles
9

Nield, Blake, Stephen R. Larsen, and Sebastiaan J. van Hal. "Clinical experience with new formulation SUBA®-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies." Journal of Antimicrobial Chemotherapy 74, no. 10 (2019): 3049–55. http://dx.doi.org/10.1093/jac/dkz303.

Full text
Abstract:
AbstractBackgroundSUper BioAvailability-itraconazole (SUBA®-itraconazole) was introduced into Australia in April 2014 as a substitute for standard itraconazole on the basis of improved bioavailability, tolerance and interpatient variability. Shortly after its introduction, our centre converted to the novel formulation for mould prophylaxis in patients undergoing allogeneic HSCT, autologous HSCT or treatment for haematological malignancies with an intermediate/high risk of invasive fungal infection (IFI).MethodsA single-institution, investigator-initiated retrospective cohort study was conducte
APA, Harvard, Vancouver, ISO, and other styles
10

Mathijssen, R. H., F. A. De Jong, D. F. Kehrer, et al. "Prophylactic treatment of irinotecan-induced diarrhea with neomycin (a randomized, placebo-controlled, double-blind study)." Journal of Clinical Oncology 24, no. 18_suppl (2006): 3626. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.3626.

Full text
Abstract:
3626 Background: Delayed-type diarrhea is a common side-effect of irinotecan, and is associated with a bacterial-mediated formation of the active irinotecan metabolite SN-38 from its glucuronide conjugate in the intestines. We hypothesized that concomitant administration of the aminoglycoside antibiotic neomycin would diminish exposure of the gut to SN-38, ameliorating the incidence of diarrhea. Methods: Patients were treated with irinotecan in a randomized, placebo-controlled, double-blind trial. In arm A, patients received irinotecan (350 mg/m2 i.v. for 90 minutes once every 3 weeks) combine
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Prophylactic treatment of diarrhoea"

1

Frank, Larry Robert Jr. "Development of Kappa Opioid Receptor Antagonists for Prophylactic Treatment of Migraine." Thesis, The University of Arizona, 2014. http://hdl.handle.net/10150/320100.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Miller, Julie Louisa. "Self-regulatory processes in patients with cardiovascular illnesses that require prophylactic treatment." Thesis, University of Brighton, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.273863.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lam, M. F., and 林文輝. "Meta-analysis of different anti-fungal prophylactic treatments in neutropenic patients." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2002. http://hub.hku.hk/bib/B3197062X.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Carlsson, Maj. "Pharmacokinetic dosing of factor VIII and factor IX in prophylactic treatment of haemophilia." Lund : Dept. of Coagulation Disorders (Dept. of Medicine, Lund University), and Hospital Pharmacy, Malmö University Hospital, 1997. http://books.google.com/books?id=DfRrAAAAMAAJ.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Marshall, Jemma E. "Prophylactic effects of mindfulness : the role of mindfulness in the treatment of anxiety." Thesis, University of Southampton, 2012. https://eprints.soton.ac.uk/347118/.

Full text
Abstract:
Mindfulness derives from meditative traditions and is a form of mental training that is increasingly incorporated into Western treatment approaches for common mental health problems. This thesis addresses the prophylactic effects of mindfulness practice and the implications for the treatment of anxiety. The first paper considers the role of attention as a predominant mechanism of mindfulness. The paper reviews the evidence for the effects of mindfulness on attentional subsets and suggests that mindfulness may in part exert its benefits by ameliorating maladaptive attentional processes that hav
APA, Harvard, Vancouver, ISO, and other styles
6

Van, Os Sandra Barbara. "A mixed methods study of adherence to prophylactic treatment among young people with haemophilia." Thesis, University of Hertfordshire, 2016. http://hdl.handle.net/2299/17227.

Full text
Abstract:
Introduction: Haemophilia is an inherited bleeding disorder caused by a deficiency in one of the coagulation or blood clotting factors in the blood. When injured someone with haemophilia does not bleed more intensely than a person without haemophilia, but they tend to bleed for a much longer time. For people affected by severe haemophilia, the deficiency in coagulation factor can cause spontaneous internal bleeding in joints and muscles, as well as intracranial bleeding, and bleeding in soft tissues (e.g. nosebleeds or bleeding gums). The most common form is Haemophilia A which is caused by a
APA, Harvard, Vancouver, ISO, and other styles
7

Mbeye, Nyanyiwe. "Use of cotrimoxazole prophylactic treatment in HIV exposed children and its impact on malaria." Thesis, University of Liverpool, 2014. http://livrepository.liverpool.ac.uk/2003300/.

Full text
Abstract:
The rapidly growing population of HIV exposed children entails widespread use of cotrimoxazole prophylactic treatment (CPT) to protect them from HIV opportunistic infections given their increased susceptibility compared to non-HIV exposed children. A number of studies have reported that CPT also provides protection against malaria but estimates of its effectiveness vary and there is little information on the impact of the prevalence of antifolate resistance mutations on its effect. Since daily CPT provides prophylaxis against malaria, it could modulate the development of malaria-specific immun
APA, Harvard, Vancouver, ISO, and other styles
8

Rayan, Paran. "The Therapeutic Applications of Medium-Chained Saturated Fatty Acids in the Treatment and Prevention of Intestinal Protozoal Infections." Thesis, Griffith University, 2010. http://hdl.handle.net/10072/367944.

Full text
Abstract:
Giardia duodenalis is a protozoal, intestinal parasite that is a common aetiological agent of infectious diarrhoea in humans worldwide. Chemotherapeutic intervention presently offers a limited range of drugs and these are usually only employed after clinical diagnosis. Moreover, these drugs are ineffective against the infectious cysts, can produce unpleasant side effects, and are expensive with limited availability in developing countries. Frequent reports of drug toxicity, treatment failure and parasite drug resistance have, in some instances, also resulted in the increasing reluctance to ove
APA, Harvard, Vancouver, ISO, and other styles
9

Spooner, Carol. "Nedocromil sodium as single dose prophylactic treatment of exercise-induced bronchoconstriction in asthma, a meta-analysis." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape17/PQDD_0002/MQ34421.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nguyen, Jill, and Sarah Workinger. "Evaluation of prophylactic voriconazole and posaconazole concentration monitoring and dose changes in liquid and solid transplant patients." The University of Arizona, 2012. http://hdl.handle.net/10150/623664.

Full text
Abstract:
Class of 2012 Abstract<br>Specific Aims: The primary aim of this study was to determine the incidence of posaconazole and voriconazole concentration monitoring that occurs in transplant patients receiving antifungal prophylaxis therapy. The secondary aim was to determine whether voriconazole and posaconazole serum concentrations were used for dose adjustments. Methods: Patients status post either a liquid or solid organ transplant over the age of 1 year who received invasive fungal infection prophylaxis with either posaconazole or voriconazole between the dates of February 1, 2010 through Jan
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Prophylactic treatment of diarrhoea"

1

A, Khan Irfan, and Khanum Atiya, eds. Herbal therapy for diarrhoea and dysentery. Ukaaz Publications, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

A, Khan Irfan, and Khanum Atiya, eds. Herbal therapy for diarrhoea and dysentery. Ukaaz Publications, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Organization, World Health, ed. The Treatment and prevention of acute diarrhoea: Practical guidelines. 2nd ed. World Health Organization, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Baqui, Abdullah H. The prevention and treatment of diarrhoea in Dhaka urban slums. International Centre for Diarrhoeal Disease Research, Bangladesh, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Morankar, Sudhakar N. Childhood diarrhoea management: Disparities in awareness and practice in a village community. Dastane Ramchandra & Co., 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Organization, World Health, and Uganda Ministry of Health, eds. Results of the WHO health facility survey of diarrhoea case management, Uganda. The Organization and the Ministry, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Jain, Narendra. Digestive diseases: Acidity, constipation, diarrhoea, gastritis, piles, ulcer, vomiting, worms. Chowkhamba Sanskrit Series Office, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

A, Cash Richard, ed. A simple solution: Teaching millions to treat diarrhoea at home. University Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Organization, World Health, ed. Treatment and prevention of acute diarrhoea: Guidelines for the trainers of health workers. World Health Organization, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Organization, World Health, ed. The Management and prevention of diarrhoea: Practical guidelines. 3rd ed. World Health Organization, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Prophylactic treatment of diarrhoea"

1

Du Port, François. "Treatment of Diarrhoea." In The Decade of Medicine or The Physician of the Rich and the Poor. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73715-2_211.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Panayiotopoulos, C. P. "Anti-epileptic Drug Prophylactic Treatment." In Principles of Therapy in the Epilepsies. Springer London, 2010. http://dx.doi.org/10.1007/978-0-85729-009-0_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Beran, Roy G. "Antiepileptic Drug Prophylactic Treatment: Overview." In Atlas of Epilepsies. Springer London, 2010. http://dx.doi.org/10.1007/978-1-84882-128-6_212.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Valeta, Thalia. "Prophylactic Treatment with Antiepileptic Drugs (AED)." In The Epilepsy Book: A Companion for Patients. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-61679-7_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shah, Mihir M., Holly J. Pederson, Risal Djohan, Joseph P. Crowe, and Stephen R. Grobmyer. "Prophylactic Risk-Reducing Surgery for Breast Cancer." In Personalized Treatment of Breast Cancer. Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55552-0_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Langer, Th, P. Krappmann, S. Kochendörfer, et al. "The Late Effects of Prophylactic CNS Treatment*." In Haematology and Blood Transfusion / Hämatologie und Bluttransfusion. Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-18156-6_61.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Miralda, G. Permanyer, and E. Galve Basilio. "Prophylactic β-blocking Treatment after Myocardial Infarction." In Therapeutics in Cardiology. Springer Netherlands, 1988. http://dx.doi.org/10.1007/978-94-009-1333-2_74.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Graft, David F. "Treatment of Hymenoptera Reactions: Acute and Prophylactic." In Stinging Insect Allergy. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-46192-2_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pommier, Pascal. "Prophylactic Treatment of the Pelvic Lymphatics: Contra." In Radiotherapy in Prostate Cancer. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/174_2013_949.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Christiansen, C. "Prophylactic treatment for age-related bone loss in women." In The Climacteric in Perspective. Springer Netherlands, 1986. http://dx.doi.org/10.1007/978-94-009-4145-8_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Prophylactic treatment of diarrhoea"

1

Kahawita, Trish, and Laurence Leong. "OP-12 Managing treatment-refractory diarrhoea in palliative care." In ANZSPM 2024 Biennial Conference. British Medical Journal Publishing Group, 2024. http://dx.doi.org/10.1136/spcare-2024-anzspm.12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tent, Michiel. "Large gaps worldwide in prophylactic treatment of migraine." In European Headache Congress, edited by Rachel Giles. Medicom Medical Publishers, 2023. http://dx.doi.org/10.55788/6e5b772e.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Poon, Dennis, Giles Major, and Jervoise Andreyev. "P294 Alternative diagnoses in patients with functional diarrhoea and treatment outcomes." In Abstracts of the BSG Annual Meeting, 20–23 June 2022. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2022. http://dx.doi.org/10.1136/gutjnl-2022-bsg.347.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fernández, C. García, C. Gómez Peña, S. Belda Rustarazo, et al. "OHP-026 Prophylactic treatment of chronic migraine with botulinum toxin: study population." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.420.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Luneva, Elena. "ROLE OF EDUCATIONAL INSTITUTIONS IN PROPHYLACTIC TREATMENT OF TAKING PSYCHOACTIVE SUBSTANCES BY YOUTH." In 5th SGEM International Multidisciplinary Scientific Conferences on SOCIAL SCIENCES and ARTS SGEM2018. STEF92 Technology, 2018. http://dx.doi.org/10.5593/sgemsocial2018/3.3/s12.090.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Milanov, P., S. Roth, A. Griesheimer, et al. "Assessing Adherence to Prophylactic Treatment in Patients with Haemophilia from Five European Countries." In GTH Congress 2024 – 68th Annual Meeting of the Society of Thrombosis and Haemostasis Research – Building Bridges in Coagulation. Georg Thieme Verlag, 2024. http://dx.doi.org/10.1055/s-0044-1779137.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pérez Puente, P., FÁ Lao Domínguez, C. Caba Hernández, A. Vaquero Montero, LC Pérez Lisón, and I. Rubio Merino. "5PSQ-068 Analysis of relapses after discontinuation of prophylactic biologic treatment in migraine." In 29th EAHP Congress, Copenhagen, Denmark, 12-13-14 March 2025, Person centred pharmacy — Navigating digital health. British Medical Journal Publishing Group, 2025. https://doi.org/10.1136/ejhpharm-2025-eahp.365.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kumar, Aditi, Niall Galbraith, Hafid Al-Hassi, et al. "P237 Treatment with bile acid sequestrants improves quality-of-life in specific patients with bile acid diarrhoea." In Abstracts of the BSG Annual Meeting, 20–23 June 2022. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2022. http://dx.doi.org/10.1136/gutjnl-2022-bsg.291.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bretones Pedrinaci, JI, A. Martos Rosa, M. Herrera Exposito, J. Urda Romacho, and MA Castro Vida. "4CPS-264 Analysis of medical treatment, risk factors and recurrence ofClostridioides difficilenosocomial diarrhoea." In 26th EAHP Congress, Hospital pharmacists – changing roles in a changing world, 23–25 March 2022. British Medical Journal Publishing Group, 2022. http://dx.doi.org/10.1136/ejhpharm-2022-eahp.414.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Santagostino, E., S. Yan, T. Matsushita, L. Alberio, and J. Davis. "Systematic Review of Efficacy of Recombinant Factor IX Products for Prophylactic Treatment of Hemophilia B." In 63rd Annual Meeting of the Society of Thrombosis and Haemostasis Research. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1680218.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Prophylactic treatment of diarrhoea"

1

Blumbergs, P., C. C. Tseng, B. S. Moss, M. T. Budrick, and C. L. Stevens. Prophylactic and Treatment Drugs for Organophosphorus Poisoning. Defense Technical Information Center, 1990. http://dx.doi.org/10.21236/ada234671.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hsieh, Patrick, Eric Apaydin, Robert G. Briggs, et al. Diagnosis and Treatment of Tethered Spinal Cord. Agency for Healthcare Research and Quality (AHRQ), 2024. http://dx.doi.org/10.23970/ahrqepccer274.

Full text
Abstract:
Objectives. To summarize the evidence regarding diagnosis, prophylactic treatment, symptomatic treatment, and repeat surgery of tethered spinal cord. Data sources. We searched PubMed®, Embase®, CINAHL, Web of Science, SCOPUS, clinicaltrials.gov, ICTRP, Cochrane Database of Systematic Reviews, PROSPERO, ECRI repository, G-I-N, MagicApp, and ClinicalKey from inception to March 2024; reference-mined reviews; and contacted research authors. Review methods. The review followed a detailed protocol and was supported by a Technical Expert Panel. Systematic review software (DistillerSR) was utilized fo
APA, Harvard, Vancouver, ISO, and other styles
3

WANG, Xuesong, Xuliang SHI, Jing LV, et al. Acupuncture and Related Therapies for anxiety and depression in Diarrhoea-Predominant Irritable Bowel Syndrome(IBS-D): A Network Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.3.0162.

Full text
Abstract:
Review question / Objective: Acupuncture-related therapies are effective Diarrhoea-Predominant Irritable Bowel Syndrome(IBS-D), therefore, our aim was to evaluate and rank the effect of different acupuncture-related therapies for the anxiety-depression status of IBS-D patients. Eligibility criteria: The published randomized controlled trials (RCTs) of acupuncture-related therapies for the treatment of IBS-D, regardless of age and sex. Clear diagnostic criteria were required to confirm the diagnosis of IBS-D, Such as Rome I, Rome II, Rome III, Rome IV, and Chinese expert consensus. Intervention
APA, Harvard, Vancouver, ISO, and other styles
4

LEONOV, T. M., V. M. BOLSHAKOVA, and P. YU NAUMOV. THEORETICAL AND LEGAL ASPECTS OF PROVIDING MEDICAL ASSISTANCE TO EMPLOYEES OF THE MILITARY PROSECUTOR’S OFFICE. Science and Innovation Center Publishing House, 2021. http://dx.doi.org/10.12731/2576-9634-2021-5-4-12.

Full text
Abstract:
The work is devoted to a comprehensive study of medical support, incl. sanatorium-resort treatment of employees of the military prosecutor’s office and members of their families (persons who are dependent on them). It is noted that health care is structurally included in services that, in addition to cash payments and benefits in kind, represent the entire social security system. The main attention in the article is focused on the analysis of the normative legal regulation of the health protection of employees of the military prosecutor’s office, as well as the provision of medical assistance
APA, Harvard, Vancouver, ISO, and other styles
5

Grueso-Navarro, Elena, Leticia Rodríguez-Alcolado, Ángel Arias, Emilio J. Laserna-Mendieta та Alfredo J. Lucendo. Influence of HLA-DQA1*05 allele in the response to anti-TNFα drugs in inflammatory bowel diseases. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.2.0076.

Full text
Abstract:
Review question / Objective: Do patients with inflammatory bowel disease and treated with any anti-TNFα drug who had the HLA-DQA1*05 allele (in heterozygosis or homozygosis) have lower response or persistence to those drugs than patients without HLA-DQA1*05 allele? Condition being studied: Inflammatory bowel diseases (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition that may affect any part of the digestive tract (CD) or be limited to the colon (UC). While the specific aetiology of IBD remains unknown, it is believed to involve a comple
APA, Harvard, Vancouver, ISO, and other styles
6

Tranchant, Jean-Pierre, Jessica Gordon, Jo Carpenter, et al. Bangladesh Initiative to Enhance Nutrition Security and Governance (BIeNGS) Final Evaluation Report. Institute of Development Studies, 2024. http://dx.doi.org/10.19088/ids.2024.036.

Full text
Abstract:
The BIeNGS programme was ultimately designed to lead to improved nutrition status of children and mothers in the two Bangladeshi districts of Jamalpur and Sherpur. This report summarises the endline findings from the evaluation of the BIeNGS programme. This comprised of a mixed methods design combining quantitative surveys with project beneficiary households, Community Clinic and CNP staff together with a qualitative and process component to gather community and implementer perspectives and process monitoring data. Quantitative findings provide a ‘before-after’ comparison of project logframe i
APA, Harvard, Vancouver, ISO, and other styles
7

Şeker, Muzaffer, Ali Özer, Zekeriya Tosun, Cem Korkut, and Mürsel Doğrul, eds. The Assessment Report on COVID-19 Global Outbreak. Türkiye Bilimler Akademisi, 2020. http://dx.doi.org/10.53478/tuba.2020.119.

Full text
Abstract:
"In late December 2019, a large number of patients with unknown causes of pneumonia were reported by press from a seafood market in Wuhan, Hubei province, China. This coronavirus was originally named the 2019 new coronavirus (2019-nCoV) by the World Health Organization (WHO) on January 12, 2020. The Coronavirus Working Group (CSG) of the WHO and International Committee proposed to call the new virus SARS-CoV-2 on February 11, 2020. As a result of the samples taken from the patient, the whole genome sequence of the SARS-CoV-2 was isolated on January 7, 2020, by Chinese scientists in a short tim
APA, Harvard, Vancouver, ISO, and other styles
8

Şeker, Muzaffer, Ali Özer, Zekeriya Tosun, Cem Korkut, and Mürsel Doğrul, eds. COVID-19 Küresel Salgın Değerlendirme Raporu. Türkiye Bilimler Akademisi, 2020. http://dx.doi.org/10.53478/tuba.2020.118.

Full text
Abstract:
"In late December 2019, a large number of patients with unknown causes of pneumonia were reported by press from a seafood market in Wuhan, Hubei province, China. This coronavirus was originally named the 2019 new coronavirus (2019-nCoV) by the World Health Organization (WHO) on January 12, 2020. The Coronavirus Working Group (CSG) of the WHO and Internati- onal Committee proposed to call the new virus SARS-CoV-2 on February 11, 2020. As a result of the samples taken from the patient, the whole genome sequence of the SARS-CoV-2 was isolated on January 7, 2020, by Chinese scientists in a short t
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!